These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 65207)
1. Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients. Fujisawa T; Waldman SR; Yonemoto RH Cancer; 1977 Feb; 39(2):506-13. PubMed ID: 65207 [TBL] [Abstract][Full Text] [Related]
2. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition. Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891 [TBL] [Abstract][Full Text] [Related]
3. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer. Halliday WJ; Koppi TA; Khan JM; Davis NC J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045 [TBL] [Abstract][Full Text] [Related]
4. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience. Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000 [TBL] [Abstract][Full Text] [Related]
5. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma. Tsang PH; Tangnavarad K; Lesnick G; Perloff M; Holland JF; Bekesi JG J Immunol Methods; 1980; 36(2):119-35. PubMed ID: 7000908 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma. McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654 [TBL] [Abstract][Full Text] [Related]
8. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI). Tsang PH; Roboz JP; Holland JF; Bekesi JG Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478 [TBL] [Abstract][Full Text] [Related]
9. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma. Winter M; Nelson DS; Milton GW Aust N Z J Med; 1980 Aug; 10(4):405-9. PubMed ID: 7000060 [TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts. Fritze D; Kaufmann M; Drings P; Fedra G Oncology; 1978; 35(6):242-5. PubMed ID: 370704 [TBL] [Abstract][Full Text] [Related]
11. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay. O'Connor R; MacFarlane JK; Murray D; Thomson DM Br J Cancer; 1978 Dec; 38(6):674-84. PubMed ID: 369586 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors. Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496 [TBL] [Abstract][Full Text] [Related]
13. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay. Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173 [TBL] [Abstract][Full Text] [Related]
14. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test]. Ludwig HJ; Storch H Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755 [TBL] [Abstract][Full Text] [Related]
15. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients. Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799 [TBL] [Abstract][Full Text] [Related]
16. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay. Shenouda G; Thomson DM Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766 [TBL] [Abstract][Full Text] [Related]
17. Leukocyte adherence inhibition assay in immunodiagnosis of colon cancers. Cavallini G; Berti G; Tioli P Ital J Surg Sci; 1984; 14(4):281-8. PubMed ID: 6398321 [TBL] [Abstract][Full Text] [Related]
18. Comparison by leukocyte adherence inhibition of human immune response to cancer-associated immunogens, Thomsen-Friedenreich (T) and Tn, myelin basic protein, and organ-specific cancer neoantigens. Thomson DM; Springer GF; Desai PR; Scanzano R; Gubersky M; Shenouda G Clin Immunol Immunopathol; 1988 Nov; 49(2):231-41. PubMed ID: 2458874 [TBL] [Abstract][Full Text] [Related]
19. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique. Kotlar HK; Sanner T J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505 [TBL] [Abstract][Full Text] [Related]
20. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer. Horváth M; Tóth L; Tóth J; Fekete B Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]